Zarządzanie ryzykiem przedsiębiorstwa farmaceutycznego

Zbigniew Galar; Adam Sadowski

doi:10.18778/8220-345-5

Keywords: przedsiębiorstwo farmaceutyczne, łańcuch dostaw, zarządzanie łańcuchem dostaw, zarządzanie ryzykiem łańcucha dostaw, ryzyko planowania produkcji

Published: 1 June 2021

Categories: Economics and management, Open Access

Downloads

PDF

Książka stanowi pierwsze na krajowym rynku wydawniczym całościowe opracowanie poświęcone zarządzaniu ryzykiem w łańcuchu dostaw przedsiębiorstwa farmaceutycznego. Zagadnienia zostały przedstawione w konwencji odpowiadającej rzeczywistemu procesowi zarządzania ryzykiem. Ułatwia to czytelnikowi zrozumienie krytycznych problemów i obszarów występujących w łańcuchu dostaw kształtujących system zarządzania ryzykiem w specyfice przedsiębiorstwa farmaceutycznego. Zaprezentowane rozważania teoretyczne są wzbogacone odniesieniami do praktycznych instrumentów zarządzania ryzykiem w postaci formuł obliczeniowych. które mogą być bezpośrednio wykorzystane przez osoby odpowiedzialne za zarządzanie ryzykiem w łańcuchu dostaw.

Adresatami publikacji są pracownicy naukowi i studenci kierunków ekonomicznych oraz pracownicy odpowiedzialni za zarządzanie ryzykiem w przedsiębiorstwach produkcyjnych, a zwłaszcza w przemyśle farmaceutycznym.

Koszty wydania niniejszej pracy zostały sfinansowane w całości przez Stowarzyszenie Zbiorowego Zarządzania Prawami Autorskimi Twórców Dzieł Naukowych i Technicznych KOPIPOL z siedzibą w Kielcach – organizację zbiorowego zarządzania prawami autorskimi do utworów naukowych.

Acosta A., Vanegas E. P., Rovira J., Godman B. et al. (2019), Medicine Shortages: Gaps Between Countries and Global Perspectives, „Frontiers in Pharmacology”, nr 10(763).

Alexander M., Kusleika D. (2014), 101 Ready to Use Excel Formulas, John Wiley & Sons, Hoboken.

Andersen T. J. (2014), Contemporary Challenges in Risk Management: Dealing with Risk, Uncertainty and the Unknown, Palgrave Macmillan, Basingstoke.

Artikis C., Artikis P. (2015), Probability Distributions in Risk Management Operations, Springer International Publishing, Heidelberg.

Baker H. K., Filbeck G. (2015), Investment Risk Management, Oxford University Press, Oxford.

Barreiro J. M., Martin-Sanchez F., Maojo V., Sanz F. (2004), Biological and Medical Data Analysis, Springer-Verlag, Berlin.

Bensoussan A., Guegan D., Tapiero C. S., Bensoussan A. (2015), Future perspectives in risk models and finance, Springer International Publishing, Heidelberg.

Bhattacharya R., Bandyopadhyay S. (2011), AReview of the Causes of Bullwhip Effect in a Supply Chain, „International Journal of Advanced Manufacturing Technology”, nr 54(9–12), s. 1245–1261.

Bhushan N., Rai K. (2004), Strategic Decision Making: Applying the Analytic Hierarchy Process, Springer-Verlag, London.

Bischof C., Wilfinger D. (2019), Big Data-Enhanced Risk Management, „Transactions of FAMENA”, nr 43(2), s. 73–84.

Borek A., Parlikad A. K., Webb J., Woodall P. (2014), Total Information Risk Management: Maximizing the Value of Data and Information Assets, Elsevier Inc., Waltham.

Boulaksil Y., Fransoo J. C. (2010), Implications of Outsourcing on Operations Planning: Findings from the Pharmaceutical Industry, „International Journal of Operations and Production Management”, nr 30(10), s. 1059–1079.

Brémaud P. (1988), An Introduction to Probabilistic Modeling, Springer Science+Business Media, New York.

Bruce P. C., Bruce A. (2017), Practical Statistics for Data Scientists: 50 Essential Concepts, O’Reilly Media, Inc., Sebastopol.

Bubnicki Z. (2004), Analysis and Decision Making in Uncertain Systems, Springer-Verlag, London.

Bucalo N., Jereb B. (2017), Risk Management in the Pharmaceutical Industry in Slovenian Companies, „Logistics & Sustainable Transport”, nr 8(1), s. 42–49.

Burinskiene A. (2019), Use of Dynamic Regression Model for Reduction of Shortages in Drug Supply, „Business, Management and Education”, nr 17(2), s. 218–231.

Bussmann S., Jennings N. R., Wooldridge M. (2004), Multiagent Systems for Manufacturing Control, Springer-Verlag, Berlin.

Campos E. A., Paula I. C., Pagani R. N., Guarnieri P. (2017), Reverse Logistics for the End-of-life and End-of-use Products in the Pharmaceutical Industry: A Systematic Literature Review, „Supply Chain Management: An International Journal”, nr 22(4), s. 375–392.

Candan G., Yazgan H. R. (2016), A Novel Approach for Inventory Problem in the Pharmaceutical Supply Chain, „DARU, Journal of Pharmaceutical Sciences”, nr 24(1), s. 4.

Capo F., Brunetta F., Boccardelli P. (2014), Innovative Business Models in the Pharmaceutical Industry: A Case on Exploiting Value Networks to Stay Competitive, „International Journal of Engineering Business Management”, nr 6(1), s. 23.

Carlberg C. G. (2011), Statistical Analysis: Microsoft Excel 2010, Pearson Education, Inc., Indianapolis.

Carroll R., ed. (2009), Risk Management Handbook for Health Care Organizations, Jossey-Bass, San Francisco.

Chan N. H., Wong H. Y. (2013), Handbook of Financial Risk Management Simulations and Case Studies, John Wiley & Sons, Inc., Hoboken.

Chan N. H., Wong H. Y. (2015), Simulation Techniques in financial Risk Management, John Wiley & Sons, Inc., Hoboken.

Chang Y. S., Makatsoris H. C., Richards H. D. (2004), Evolution of Supply Chain Management: Symbiosis of Adaptive Value Networks and ICT, Kluwer Academic Publishers, Boston.

Cox L. A. (2012), Improving Risk Analysis, Springer Science+Business Media, New York.

Cox L. A. (2015), Breakthroughs in Decision Science and Risk Analysis, John Wiley & Sons, Inc., Hoboken.

De Felice F., Petrillo A., Autorino C. (2014), Maintenance Strategies and Innovative Approaches in the Pharmaceutical Industry: An Integrated Management System (ims), „International Journal of Engineering Business Management”, nr 6(1), s. 29.

Desel J., Pernici B., Weske M. (2004), Business Process Management, Springer-Verlag, Berlin.

Deselnicu D. C., Negoita O. D., Purcarea A. A. (2018), Risk Analysis for Performance Improvement in a Romanian Pharmaceutical Company, „TEM Journal”, nr 7(2), s. 319–323.

Duong M., Moles R. J., Chaar B., Chen T. F. (2015), Essential Medicines in a High Income Country: Essential to Whom?, „PLoS ONE”, nr 10(12), s. e0143654.

Enyinda C. I., Mbah C. H., Ogbuehi A. (2010), An Empirical Analysis of Risk Mitigation in the Pharmaceutical Industry Supply Chain: A Developing-country Perspective, „Thunderbird International Business Review”, nr 52(1), s. 45–54.

Friemann F., Schönsleben P. (2016), Reducing Global Supply Chain Risk Exposure of Pharmaceutical Companies by Further Incorporating Warehouse Capacity Planning into the Strategic Supply Chain Planning Process, „Journal of Pharmaceutical Innovation”, nr 11(2), s. 162–176.

Galar Z. (2019), Zarządzanie ryzykiem w przedsiębiorstwach sektora farmaceutycznego [Dysertacja doktorska, Politechnika Częstochowska Wydział Zarządzania], Częstochowa.

Galar Z., Sadowski A. (2014a), Optymalizacja wielkości kapitału zamrożonego w zapasach fabryki leków z perspektywy zarządzania ryzykiem (cz. 1), „Logistyka”, nr 5, s. 1812–1816.

Galar Z., Sadowski A. (2014b), Optymalizacja wielkości kapitału zamrożonego w zapasach fabryki leków z perspektywy zarządzania ryzykiem (cz. 2), „Logistyka”, nr 5, s. 1817–1821.

Galbreth M. R., LeBlanc L. J. (2010), Overcoming Spreadsheet Risk In Supply Chain Modeling, „Journal of Business Logistics”, nr 31(2), s. 21–33.

Glau K., Scherer M., Zagst R. (2013), Innovations in Quantitative Risk Management, Springer International Publishing, München.

Glendon I. A., Clarke S. (2016), Human Safety and Risk Management: A Psychological Perspective, Taylor & Francis Group, LLC, Boca Raton.

Hager R. (2011), The Growing Importance of Cold Chain Management in Biopharmaceutical Development, „BioProcessing Journal”, nr 10(2), s. 17–20.

Hand D. J., Mannila H., Smyth P. (2001), Principles of Data Mining, MIT Press, Cambridge.

Harrison T. P., Lee H. L., Neale J. J. (2005), The Practice of Supply Chain Management: Where Theory and Application Converge, Springer Science&Business Media, Inc., Boston.

Heinonen L., Somsen H. (2008), Money for Nothing? Risks in Biopharmaceutical Companies from the Perspective of Public Financiers, „Journal of Commercial Biotechnology”, nr 14(4), s. 287– 298.

Hull J. (2015), Risk Management and Financial Institutions, John Wiley & Sons, Inc., Hoboken.

Huq F., Pawar K. S., Rogers H. (2016), Supply Chain Configuration Conundrum: How Does the Pharmaceutical Industry Mitigate Disturbance Factors?, „Production Planning and Control”, nr 27(14), s. 1206–1220.

Iyengar S., Hedman L., Forte G., Hill S. (2016), Medicine Shortages: A Commentary on Causes and Mitigation Strategies, „BMC Medicine”, nr 14(1), s. 124.

Jaberidoost M., Olfat L., Hosseini A., Kebriaeezadeh A. et al. (2015), Pharmaceutical Supply Chain Risk Assessment in Iran Using Analytic Hierarchy Process (AHP) and Simple Additive Weighting (SAW) Methods, „Journal of Pharmaceutical Policy and Practice”, nr 8(1), s. 9.

Jacod J., Protter P. (2004), Probability Essentials, Springer-Verlag, Berlin.

Jauhar S. K., Pant M. (2016), Genetic Algorithms in Supply Chain Management: A Critical Analysis of the Literature, „Sadhana – Academy Proceedings in Engineering Sciences”, nr 41(9), s. 993– 1017.

Jensen C. D., Poslad S., Dimitrakos T. (2004), Trust Management, Springer-Verlag, Berlin.

Jia F., Rutherford C. (2010), Mitigation of Supply Chain Relational Risk Caused by Cultural Differences between China and the West, „International Journal of Logistics Management”, nr 21(2), s. 251–270.

Jorion P. (2003), Financial Risk Manager Handbook, John Wiley & Sons, Inc., Hoboken.

Krichanchai S., MacCarthy B. L. (2017), The Adoption of Vendor Managed Inventory for Hospital Pharmaceutical Supply, „International Journal of Logistics Management”, nr 28(3), s. 755–780.

Kumar N., Jha A. (2018), Quality Risk Management during Pharmaceutical ‘Good Distribution Practices’ – A Plausible Solution, „Bulletin of Faculty of Pharmacy, Cairo University”, nr 56(1), s. 18–25.

Kumar Sharma S., Sharma S. (2015), Developing a Bayesian Network Model for Supply Chain Risk Assessment, „Supply Chain Forum”, nr 16(4), s. 50–72.

Larose D. T. (2006), Data Mining Methods and Models, John Wiley & Sons, Inc., Hoboken.

Leidner J. L. (2015), Computer-Suported Risk Identification for the Holistic Management of Risks, preprint.

Lemieux V. L. (2013), Financial Analysis And Risk Management: Data Governance, Analytics and Life Cycle Management, Springer Verlag, Berlin.

Lewin J. J., Choi E. J., Ling G. (2016), Pharmacy on Demand: New Technologies to Enable Miniaturized and Mobile Drug Manufacturing, „American Journal of Health-System Pharmacy”, nr 73(2), s. 45–54.

Lewis N. D. (2012), The Fundamental Rules of Risk Management, Taylor & Francis Group, LLC, Boca Raton.

Liebowitz J. (1998), The Handbook of Applied Expert Systems, CRC Press, Boca Raton.

Louisot J., Ketcham C. H. (2014), ERM – Enterprise Risk Management: Issues and Cases, John Wiley & Sons Ltd, Chichester.

Lücker F., Seifert R. W. (2017), Building up Resilience in a Pharmaceutical Supply Chain through Inventory, Dual Sourcing and Agility Capacity, „Omega”, nr 73, s. 114–124.

Marques C. M., Moniz S., de Sousa J. P., Barbosa-Povoa A. P. et al. (2020), Decision-support Challenges in the Chemical-pharmaceutical Industry: Findings and Future Research Directions, „Computers & Chemical Engineering”, nr 134, s. 1066–1072.

Mattke S., Klautzer L., Mengistu T. (2012), Medicines as a Service: A New Commercial Model for Big Pharma in the Postblockbuster World, RAND Health.

Mayall S. J., Banerjee A. K. (2014), Therapeutic Risk Management of Medicines, Woodhead Publishing Limited, Cambridge.

Mehralian G., Zarenezhad F., Ghatari A. R. (2015), Developing a Model for an Agile Supply Chain in Pharmaceutical Industry, „International Journal of Pharmaceutical and Healthcare Marketing”, nr 9(1), s. 74–91.

Millward S. (2017), China’s JD Opens Fully Automated Sorting Center, https://www.techinasia.com/china-fully-automated-sorting-center-jd-ecommerce (dostęp: 22.11.2020).

Moktadir M. A., Ali S. M., Mangla S. K., Sharmy T. A., et al (2018), Decision Modeling of Risks in Pharmaceutical Supply Chains, „Industrial Management and Data Systems”, nr 118(7), s. 1388– 1412.

Molak V. (1997), Fundamentals of Risk Analysis and Risk Management, CRC Press, Inc., Boca Raton.

Moran A. (2014), Agile Risk Management, Springer, Heidelberg.

Muckstadt J. A., Sapra A. (2010), Principles of Inventory Management: When You Are Down to Four, Order More, Springer Science+Business Media, LLC, New York.

Muller M. (2003), Essentials of Inventory Management, AMACOM, New York.

Mun J. (2006), Modeling Risk: Applying Monte Carlo Simulation, Real Options Analysis, Forecasting, and Optimization Techniques, John Wiley & Sons, Hoboken.

Olson D. L. (2014), Supply Chain Risk Management: Tools for Analysis, Business Expert Press, LLC, New York.

Owsian P. Ł., Osińska M. (2016), Zarządzanie ryzykiem w przedsiębiorstwie z wykorzystaniem wybranych metod ilościowych, Wydawnictwo Naukowe Uniwersytetu Mikołaja Kopernika, Toruń.

Paciarotti C., Mazzuto G., D’Ettorre D. (2014), A Revised FMEA Application to the Quality Control Management, „International Journal of Quality and Reliability Management”, nr 31(7), s. 788–810.

Papert M., Rimpler P., Pflaum A. (2016), Enhancing Supply Chain Visibility in a Pharmaceutical Supply Chain: Solutions Based on Automatic Identification Technology, „International Journal of Physical Distribution and Logistics Management”, nr 46(9), s. 859–884.

Pariazar M., Sir M. Y. (2018), A Multi-objective Approach for Supply Chain Design Considering Disruptions Impacting Supply Availability and Quality, „Computers and Industrial Engineering”, nr 121, s. 113–130.

Pérez-Salazar M. D., Lasserre A. A., Cedillo-Campos M. G., González J. C. (2017), The Role of Knowledge Management in Supply Chain Management: A Literature Review, „Journal of Industrial Engineering and Management”, nr 10(4), s. 711–788.

Pickett S. K. (2005), Auditing the Risk Management Process, Wiley & Sons, Inc., Hoboken.

Rajendran A. (2012), Qlikview for Enterprises A Practitioner’s Reference, Rajendran.

Robert C. P., Casella G. (2004), Monte Carlo Statistical Methods, Springer Science+Business Media Inc., New York.

Rossetti C. L., Handfield R., Dooley K. J. (2011), Forces, Trends, and Decisions in Pharmaceutical Supply Chain Management, „International Journal of Physical Distribution and Logistics Management”, nr 41(6), s. 601–622.

Schapranow M. P., Müller J., Zeier A., Plattner H. (2012), Costs of Authentic Pharmaceuticals: Research on Qualitative and Quantitative Aspects of Enabling Anti-counterfeiting in RFID-aided Supply Chains, „ Personal and Ubiquitous Computing”, nr 16(3), s. 271–289.

Schweitzer S. O., Lu J. Z. (2018), Pharmaceutical Economics and Policy: Perspectives, Promises, and Problems, Oxford University Press, New York.

Sethi S. P., Yan H., Zhang H. (2005), Inventory and Supply Chain Management with Forecast Updates, Springer Science+Business Media, Inc., New York.

Sharma S., Modgil S. (2019), TQM, SCM and Operational Performance: An Empirical Study of Indian Pharmaceutical Industry, „Business Process Management Journal”, nr 26(1), s. 331–370.

Sondaż: Niemal wszyscy lekarze spotykają się z przedstawicielami producentów leków (2017), https://forsal.pl/artykuly/1074053,sondaz-niemal-wszyscy-lekarze-spotykaja-sie-z-przedstawicielami-producentow-lekow.html (dostęp: 22.11.2020).

Sutton I. (2015), Process Risk and Reliability Management, Elsevier Inc., Oxford.

Taylor C. E. (2015), Robust Simulation for Mega-Risks, Springer International Publishing, Heidelberg.

Tomanek M., Juricek J. (2015), Project Risk Management Model Based on PRINCE2 and Scrum Frameworks, „International Journal of Software Engineering & Applications”, nr 6(1), s. 81–88.

Tucker A. B. (2004), Computer Science Handbook, Chapman & Hall/CRC, Boca Raton.

Urbanowska-Sojkin E. (2013), Ryzyko w wyborach strategicznych w przedsiębiorstwach, Polskie Wydawnictwo Ekonomiczne, Warszawa.

Virglerova Z. (2018), Differences in the Concept of Risk Management in V4 Countries, „International Journal of Entrepreneurial Knowledge”, nr 6(2), s. 100–109.

Wang J. (2009), Encyclopedia of Data Warehousing and Mining, IGI Global, Hershey.

Wang M., Jie F. (2019), Managing Supply Chain Uncertainty and Risk in the Pharmaceutical Industry, „Health Services Management Research”, nr 33(3), s. 156–164.

Waters D. (2007), Supply Chain Risk Management: Vulnerability and Resilience in Logistics, Kogan Page Limited, London.

Wild A. (2002), Best Practice in Inventory Management, Elsevier Science Ltd., Oxford.

Williams D. R., Spaulding T. J. (2018), The Inherent Risks Associated with Newly Traded Biopharmaceutical Firms, „Drug Discovery Today”, nr 23(9), s. 1680–1688.

Wolke T. (2017), Risk Management, De Gruyter Oldenbourg, München.

Wróblewski D., Abgarowicz G., Abgarowicz I., Banulska A. et al. (2015), Zarządzanie ryzykiem. Przegląd wybranych metodyk, Centrum Naukowo-Badawcze Ochrony Przeciwpożarowej im. Józefa Tuliszkowskiego, Józefów.

Wu D. D., Chen S. H., Olson D. L. (2014), Business Intelligence in Risk Management: Some Recent Progresses, Information Sciences, nr 256, s. 1–7.

Wu D. D., Olson D. L. (2015), Enterprise Risk Management, Palgrave Macmillan UK, London.

Zhang M., Kulwant P. S., Shah J., Mehta P. (2013), Evaluating Outsourcing Partners’ Capability: A Case Study from the Pharmaceutical Supply Chain, Journal of Manufacturing Technology Management, nr 24(8), s. 1080–1101.

Zhong R. Y., Newman S. T., Huang G. Q., Lan S. (2016), Big Data for Supply Chain Management in the Service and Manufacturing Sectors: Challenges, Opportunities, and Future Perspectives, „Computers and Industrial Engineering”, nr 101, s. 572–591.

Downloads

Download data is not yet available.

License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite

Galar, Zbigniew, and Adam Sadowski. 2021. Zarządzanie Ryzykiem przedsiębiorstwa Farmaceutycznego. Poland: Lodz University Press. https://doi.org/10.18778/8220-345-5.